About this trial
HELP-A study is a single-center, randomized, controlled trial. A total of 588 patients enrolled during the 2 years of enrollment period and followed for 1 month of follow-up period. This study aims to compare diagnostic yield between continuous ECG Patch and intermittent handheld ECG in patients with arrhythmia symptoms.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who have arrhythmia symptoms but are not diagnosed on a 12-lead electrocardiogram and require additional tests.
Patients who can use a smartphone
Disqualifiers
Patients who have cardiac implantable electronic devices(CIEDs)
Patients who can't use handheld ECG
Trial design
Parallel
Treatments tested in this trial
Continous ECG Patch
DeviceUsing a continuous patch ECG for 1 week during 1 month
Intermittent handheld ECG
DeviceUsing a handheld ECG twice daily and when symptoms are present during 1 month
Treatment groups
Trial outcomes
Primary outcomes
Diagnostic yield
(Number of patient with triggered event without arrhythmia + Number of patients with clnically significant arrhytmia) / total patients
Secondary outcomes
Arrhythmia detection rate
Compare the arrhythmia diagnosis rate between the two devices.
Cost-effectiveness
Compare Total medical cost incurred for arrhythmia symptoms between the two devices
Chagne of Quality of Life
Compare Quality Of Life using Euro QOL-5D-5L between the two devices
User convenience
Comparison of User convenience using questionnaires in patients who used both devices (ease, portability, satisfaction, etc.) The questionnaire consists of 5 scales from 1 to 5
Sponsors and contacts
Click on the lead sponsor to view all of their trials.